1. [The alternative NF-kB activation pathway and cancer: friend or foe?]
- Author
-
Véronique, Baud and Emilie, Jacque
- Subjects
Proteasome Endopeptidase Complex ,Lymphoma ,Models, Genetic ,Transcription Factor RelB ,NF-kappa B ,Ubiquitination ,Apoptosis ,Mice, Transgenic ,I-kappa B Kinase ,Neoplasm Proteins ,Gene Expression Regulation, Neoplastic ,Mice ,Neoplasms ,Vertebrates ,Animals ,Humans ,Receptors, Cytokine ,Dimerization ,Protein Processing, Post-Translational ,Cell Division - Abstract
The family of NF-kappaB transcription factors plays a key role in diverse biological processes, such as inflammatory and immune responses, cell survival and tumor development. A new NF-kappaB activation pathway has been recently uncovered, the so-called alternative NF-kappaB activation pathway. It has been shown that this pathway mainly controls the activity of RelB, a member of the NF-kappaB family, and its activation requires IKKalpha, one of the two catalytic subunits of the IKK complex. Recent studies suggest that constitutive activation of the alternative pathway may be involved in tumor development, but most surprisingly it is also reported that IKKalpha exerts a protective function against uncontrolled cell proliferation and cancer development. This review discusses recent progresses in the understanding on how the alternative pathway may participate in cancer development, focusing more specifically on RelB and IKKalpha.
- Published
- 2009